Pharmacovigilance & Biologic Drug Safety

A critical track dedicated to ensuring post-market safety of biologics. Experts will cover signal detection, AI-enabled safety analytics, global PV regulations, and risk–benefit evaluation. Discussions will highlight challenges in managing biologic adverse events, multi-country reporting, and QPPV responsibilities. Case studies will illustrate how proactive PV systems enhance patient trust and therapeutic reliability.

    Related Conference of Pharmacovigilance & Biologic Drug Safety

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmacovigilance & Biologic Drug Safety Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in